| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Mar-07 | | Total Revenue | 51,595 | 42,763 |
-
| | Cost of Revenue | 42,026 | 34,226 |
-
| | | Gross Profit | 9,569 | 8,537 |
-
| | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 4,425 | 3,375 | 42 | | Non Recurring |
-
|
-
| 0 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 5,144 | 5,161 | (42) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 396 | (116) |
-
| | Earnings Before Interest And Taxes | 5,540 | 5,046 | (42) | | Interest Expense | 113 | 96 |
-
| | Income Before Tax | 5,426 | 4,949 | (42) | | Income Tax Expense | 547 | 409 |
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,879 | 4,540 | (42) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 4,879 | 4,540 | (42) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,879 | $4,540 | ($42) |
|
0.34% Nasdaq 
Income Statement
